Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$772
|
$728B |
13.7x |
34.1x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$186
|
$394B |
6.8x |
14.9x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$155
|
$387B |
4.3x |
11.8x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$82
|
$230B |
3.6x |
8.2x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$293
|
$206B |
6.0x |
11.0x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$418
|
$186B |
4.3x |
17.1x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$184B |
2.9x |
7.5x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$109
|
$153B |
5.3x |
11.9x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$193
|
$153B |
6.3x |
20.0x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$46
|
$134B |
2.8x |
10.6x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$464
|
$115B |
10.0x |
34.8x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$153
|
$73.1B |
7.8x |
18.1x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$527
|
$43.3B |
10.7x |
31.5x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$311
|
$39.2B |
15.0x |
210.2x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$113
|
$34.1B |
5.1x |
17.4x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$246
|
$26.7B |
2.0x |
11.7x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1169
|
$26.3B |
6.7x |
21.2x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$166
|
$25.0B |
2.4x |
12.1x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$23.9B |
1.7x |
5.5x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$128
|
$22.7B |
2.4x |
7.1x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$150
|
$19.7B |
10.6x |
-76.2x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$103
|
$19.5B |
46.6x |
-21.1x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$290
|
$18.4B |
6.0x |
16.7x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$24
|
$17.7B |
N/A |
-68.2x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$97
|
$16.7B |
3.9x |
14.8x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$146
|
$14.6B |
1.8x |
8.8x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$96
|
$13.5B |
4.8x |
15.6x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$131
|
$12.5B |
4.9x |
20.7x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$10.9B |
1.7x |
5.6x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$68
|
$10.8B |
2.4x |
15.9x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$47
|
$10.7B |
5.3x |
14.3x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$111
|
$10.5B |
4.0x |
-7.2x |
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$154
|
$10.3B |
2.6x |
10.7x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$47
|
$10.2B |
28.5x |
-21.9x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$57
|
$10.2B |
3.4x |
13.0x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$293
|
$10.1B |
3.3x |
6.2x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$112
|
$9.6B |
2.3x |
7.4x |
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$313
|
$8.7B |
4.0x |
18.2x |
Bio-Techne
|
United States of America |
Laboratory Services,
Pharma Diagnostics & Analytics
|
$51
|
$8.3B |
6.8x |
19.8x |
Blueprint Medicines
|
United States of America |
Drug Development & Therapeutics
|
$129
|
$8.2B |
13.2x |
-78.3x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$57
|
$7.7B |
6.8x |
10.7x |
Stevanato Group
|
United States of America |
Medical Supplies,
Drug Delivery Systems
|
$26
|
$7.3B |
5.7x |
23.5x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$71
|
$7.3B |
9.1x |
N/A |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$32
|
$7.0B |
2.7x |
-1.8x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$27
|
$6.9B |
1.6x |
9.1x |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$40
|
$6.6B |
7.9x |
-44.8x |
Guardant Health
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$48
|
$6.6B |
8.0x |
-27.4x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$311
|
$6.2B |
13.7x |
-14.2x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$42
|
$5.9B |
8.1x |
-13.2x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$5.9B |
12.8x |
53.7x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$110
|
$5.3B |
10.5x |
-29.2x |
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$81
|
$5.3B |
3.4x |
7.8x |
Sotera Health
|
United States of America |
Laboratory Services,
Medical Supplies
|
$11
|
$5.3B |
4.7x |
9.4x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$5.1B |
1.8x |
7.9x |
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$83
|
$4.9B |
N/A |
-15.2x |
Nomad Foods
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$17
|
$4.7B |
1.4x |
7.5x |
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$75
|
$4.6B |
4.1x |
12.3x |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$4.4B |
215.5x |
-7.4x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$18
|
$4.3B |
9.2x |
21.1x |
Soleno Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$84
|
$4.2B |
76.2x |
N/A |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$29
|
$3.9B |
2.7x |
10.5x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$43
|
$3.9B |
N/A |
N/A |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$3.8B |
6.5x |
21.0x |
Endo
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$21
|
$3.7B |
N/A |
N/A |
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$148
|
$3.7B |
10.5x |
27.9x |
Merus
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$3.6B |
77.3x |
-12.4x |
Akero Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$52
|
$3.5B |
N/A |
-10.9x |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$3.4B |
879.3x |
-11.9x |
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$68
|
$3.3B |
38.0x |
-17.2x |
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$3.1B |
3.0x |
19.7x |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$35
|
$3.0B |
N/A |
N/A |
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$53
|
$2.9B |
73.8x |
-6.4x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$2.9B |
48.9x |
N/A |
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$45
|
$2.8B |
43.0x |
-10.4x |
MoonLake
|
United States of America |
Drug Development & Therapeutics
|
$50
|
$2.7B |
N/A |
-15.4x |
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$52
|
$2.6B |
6.6x |
-53.1x |
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$2.6B |
1.2x |
28.3x |
Viking Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$2.6B |
3272.0x |
-14.2x |
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$19
|
$2.5B |
3.3x |
-21.3x |
BioCryst Pharma
|
United States of America |
Drug Development & Therapeutics
|
$9
|
$2.3B |
4.3x |
45.3x |
Immunovant
|
United States of America |
Drug Development & Therapeutics
|
$17
|
$2.3B |
814.9x |
-5.1x |
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$124
|
$2.2B |
12.1x |
37.8x |
Twist Bioscience
|
United States of America |
Genomics & Personalized Medicine,
Bioinformatics
|
$36
|
$2.0B |
5.5x |
-15.5x |
Catalyst Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$2.0B |
3.7x |
8.4x |
Phibro Animal Health
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$1.9B |
1.5x |
10.1x |
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$63
|
$1.9B |
N/A |
N/A |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$64
|
$1.9B |
2.7x |
10.4x |
Xenon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$1.9B |
468.3x |
-6.1x |
Vericel
|
United States of America |
Regenerative Medicine,
Drug Development & Therapeutics
|
$37
|
$1.9B |
7.0x |
28.7x |
Certara
|
United States of America |
Health Data & Analytics,
Drug Development & Therapeutics
|
$10
|
$1.8B |
4.5x |
14.3x |
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$28
|
$1.8B |
3.5x |
150.4x |
BGM Group
|
United States of America |
Drug Development & Therapeutics
|
$9
|
$1.8B |
N/A |
N/A |
Crinetics Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$32
|
$1.8B |
533.8x |
-4.6x |
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$1.7B |
6.8x |
-18.8x |
Veracyte
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$25
|
$1.7B |
3.7x |
17.1x |
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$1.7B |
3.0x |
-39.2x |
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$32
|
$1.7B |
2.4x |
4.0x |
Harmony Biosciences Hldgs
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$1.7B |
2.1x |
6.3x |
Apogee Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$1.7B |
N/A |
-6.6x |
Adaptive Biotech
|
United States of America |
Pharma Diagnostics & Analytics,
Drug Development & Therapeutics
|
$11
|
$1.6B |
7.9x |
-25.8x |